BIOX ApS: Financial statements 2024
CVR: 40237216
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOX ApS (CVR 40237216) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,091 and a net result of DKK -5,706 compared with DKK -20,978 the year before. Equity in the 2024 report amounted to DKK 992,006. The solvency ratio was 91.3%.
- Gross Profit
- DKK -7,091
- Profit/Loss
- DKK -5,706
- Equity
- DKK 992,006
- Total Assets
- DKK 1,086,646
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -7 t. | -6 t. | 992 t. | - |
| 2023 | - | -26 t. | -21 t. | 998 t. | - |
| 2022 | - | 2 t. | -69 t. | 515 t. | 1 |
| 2021 | - | -71 t. | -70 t. | 584 t. | 1 |
| 2020 | - | -79 t. | -442 t. | 654 t. | 2 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOX ApS has published its annual report for 2023. Gross profit came to DKK -25,645, and the net result was DKK -20,978.
About BIOX ApS
BIOX ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Lindblad. The company's owners include LOVISION ApS, BiA ApS and Genesis Invest ApS. In 2025, the company reported a gross profit of DKK 20,636 and a net result of DKK 15,931 compared with DKK -5,706 the year before. Equity in the 2025 report amounted to DKK 1,007,937.